|  | | |
|
Women In Biotech Panel Discussion
|
| Date: |
Tuesday May 6, 2008 |
| Description: |
Harvard Biotech Club panel discussion speakers:
Mara Aspinall
President, Genzyme Genetics
Nadine Cohen
Senior Vice-President, Biogen Idec
Panel discussion:
WOMEN IN BIOTECH
Our speakers will talk about their career paths, commercialization of science and the future of biotech/pharma industries.
Tuesday, May 6th
5:00pm - 7:00pm
TMEC amphitheater
260 Longwood Ave., HMS
refreshments/pizza provided
About the speakers:
MARA ASPINALL is the President of Genzyme Genetics. Under Mara's leadership, Genzyme Genetics has expanded its range and reach in the diagnostics marketplace. The division has successfully completed and integrated four acquisitions, expanded research and development programs, and initiated new programs for community outreach and education. Her MBA from Harvard Business School was enriched with the John P. Stevens Prize for leadership. She has served on the board of the HBS Network for Women. A magna cum laude graduate of Tufts University, Mara majored in International Relations.
NADINE COHEN is the Senior Vice President of Regulatory Affairs at Biogen Idec. Dr. Cohen was previously Director of Regulatory Affairs. She joined Biogen in 1999 from the Massachusetts Biologics Laboratories, where she was Senior Director of Quality Control and Technical Services. Prior to that, she was Vice President of Regulatory Affairs and Quality at Alpha Beta Technology, Inc. Dr. Cohen obtained her B.S. in Biology from Rensselaer Polytechnic Institute, and her Ph.D. in Biochemistry from the University of Rochester.
For more information, please visit:
|
| File Attachments: |
File (None)
 JPEG(None)
 PDF(None)
|
|
Technium Challenge International: BPlan competition
|
| Date: |
Friday March 28, 2008 |
| Description: |
GLOBAL BUSINESS COMPETITION OFFERS ENTREPRENEURS
CHANCE TO WIN ONE YEAR’S FREE OFFICE SPACE IN UK INCUBATOR
Sony Corporation Chairman & CEO Howard Stringer To Judge Second Annual Technium Challenge International
American entrepreneurs can gain a foothold into the European market by participating in the second annual Technium Challenge International, a global business planning competition operated by Technium, a network of business incubators, and International Business Wales.
The winner of the contest will earn one year of free office space within one of 10 Technium incubators in Wales, strategic counsel on financing, business planning, technical issues, as well as valuable networking opportunities. Judges include Sony Corporation Chairman and CEO Howard Stringer, a Welshman, as well as Gordon Innes, Director of UK Trade & Investment USA, and Geraint Jones, Chief Executive, Americas, International Business Wales.
“This unique global competition offers a big boost to small businesses seeking resources to grow their business internationally,” said Geraint Jones of International Business Wales. “Wales is an ideal location for companies seeking to gain entrance into the European marketplace, due to our close proximity to London, state-of-the-art telecommunications infrastructure, solid workforce and superior universities.”
U.S. entries must be submitted by March 28, 2008, for review by a local judging panel, where a short list of successful applicants will be selected by early April 2008. These companies will then undergo a final round of judging before the American winner is announced in late April 2008.
Wales’ International Technium Challenge is open to companies from the USA, Australia, New Zealand, China, India, Japan, Korea, South Africa and France. In late May 2008, a representative of the winners from each country, including the USA, will be flown to Wales for a week-long “Learning Journey” that will include one-on-one sessions with U.K. legal and business experts.
Finalists will receive introductions to established business networks, direct guidance on developing a U.K. market entry business plan, as well as detailed briefings about European markets. From there, they will present their business plans in front of the final Technium judging panel, which will determine one overall winner.
Detailed information about the competition including submission deadlines, terms and conditions, and background on last year’s winner is available on the Technium Challenge International website, www.technium.co.uk/challengeinternational.
About Technium
Technium is a network of innovation centers in Wales/UK supporting the growth of technology companies. Technium offers the optimum environment to enable knowledge-based start-up and spin-out companies to realise their potential. Technium includes a network of state-of-the-art facilities across Wales served by the latest information technology and fibre optic bandwidth capabilities. Inside Technium, companies are supported by a team of business and technical support staff and have access to specialist laboratory facilities and communal networking areas. Strong partnerships forged between Technium and local Centres of Research Excellence provide specialist academic support for research & development projects. For more information, visit www.technium.co.uk.
About International Business Wales
International Business Wales is the economic development arm of the Welsh Assembly Government with the responsibility of helping international corporations locate operations in Wales, and with promoting international trade by Welsh businesses. IBW can assist businesses in finding suitable properties in Wales for their operations, help them in finding employees and in obtaining financial assistance from the Welsh government, when appropriate. For more information, visit www.ibwales.com
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
TiE - Boston: The Oncology Revolution Panel Discussion
|
| Date: |
Thursday February 28, 2008 |
| Description: |
TiE - Boston and Harvard Biotech Club invite you to a panel discussion on
"The Oncology Revolution”
Emerging Opportunities in Cancer Therapy and Diagnostics for Entrepreneurs, Investors, Researchers and Students
Oncology is poised to become the biggest therapeutic segment by 2010. As surgery, radiotherapy and drug treatment is leading way to targeted therapies, the next generation of therapeutic and diagnostic interventions are fundamentally transforming the management of cancers. A distinguished panel of experts will share insights about emerging trends in cancer therapeutics and diagnostics. The panel will discuss the opportunities in academia and industry and share their vision of cancer treatment. Two young startups will also showcase their innovations and discuss how they bridged the gap between research and industry.
Panelists
- Mara Aspinall, MBA, President – Genetics, Genzyme
- George D. Demetri, MD, Director, Ludwig Center, Dana-Farber Cancer Institute
- Steven Tregay, PhD, Managing Director, Novartis Venture Funds (Moderator)
- Elan Ezickson, JD, Chief Business Officer, Aveo Pharma
- Janina Longtine, MD, Chief, Molecular Diagnostics, Brigham & Women’s Hospital
- Shuji Ogino, MD, PhD, Deptt. of Molecular Oncologic Pathology, Dana Farber Cancer Institute
Presentations
- Mike Boss, PhD, Xanthus Pharmaceuticals
Venue:
Armenise Amphitheater, Harvard Medical School
210 Longwood Ave, Boston, Massachusetts 02115
Directions: http://hms.harvard.edu/hms/maps.asp
Parking: There is limited street parking. Parking garages are at 300, 333 and 350 - Longwood Ave, Boston, MA 02115
Date:
February 28, 2008; Thursday
Time:
Networking & Dinner 5:30 to 6:30 pm
Panel Discussion 6:30 to 8 pm
Presentations 8 to 8:30 pm
Registration
Please register for this event at: https://www.123signup.com/event?id=txxfx. For more information contact Suchitra (781-272-3875, suchitra@tie-boston.org). Harvard, MIT, Partners Healthcare and Care Group affiliates can RSVP to pushwaz@thebiotechclub.org with their department affiliation, official email id and contact number for free admission. The seating is limited.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Sachs Associates 7th ANNUAL NORTH AMERICA FORUM
|
| Date: |
Monday February 25, 2008 |
| Description: |
7th ANNUAL NORTH AMERICA FORUM
FOR INVESTING & PARTNERING
IN BIOTECH
25 - 26 February 2008, Fairmont Copley Plaza, Boston
Sponsored by:
CBT Advisors | Edwards Angell Palmer & Dodge | Katan Associates | Lexicon Pharmaceuticals
Sachs Associates is a London based company organizing large-scale investor conferences. We hold Biotechnology Forums annually – in Zurich, London and in Boston, to which we invite a selected audience of approx. 400 pharmas, emerging biotechs & investors. The North America Forum is a well established conference going into its 7th year, which focuses on bridging the North American and European Biotech communities
‘The North America Forum’ boasts excellent participation from Europe and the U.S., plus a wider inclusion of regional hotspots. The event is highly transactional, featuring over 60 presentations by a range of early stage to pre-IPO and public life science companies in sector-specific workshops e.g. Therapeutics, Oncology, Medical Device etc. These workshops are interspersed with conference roundtables featuring big pharmaceuticals, investors, tech transfer units etc.
This Forum is designed to bring together all executives in an informal setting for substantive conversations, giving the chance to forge new alliances and partnerships, renew old ones, and secure financing for new initiatives. Presenting at this leading Forum offers a company the opportunity to raise its profile to the larger financial community and provides the chance to communicate face to face with fund managers and advisers. As a result, Sachs Associates events have always provided a fertile ground for million-dollar agreements and ground-breaking partnerships.
Confirmed speakers include:
• Michael F. Bigham, Partner, Abingworth Mangement
• John Maraganore, President & CEO, Alnylam Pharmaceuticals
• Bruce Booth, Principal, Atlas Venture
• Doug Cole, General Partner, Flagship Ventures
• Ansbert Gadicke, General Partner, MPM Capital
• Michael Lytton, General Partner, Oxford Bioscience Partners
• John Brooks, General Partner, Prism VentureWorks
• Lutz Giebel, Managing Partner, SV Life Sciences
• Jens Eckstein, Partner, TVM Capital
For more information, please visit www.sachsforum.com
Working alongside Sachs Associates, GSAS Harvard Biotechnology Club has negotiated discounted fees for our members (only applicable to members who have not already confirmed a slot in Boston).
Should you have any queries, wish to apply as a presenting company, delegate or for complimentary places for institutional investors please contact Abel Jimenez Ramon on +44 (0) 20 7405 5579 or abel@sachsforum.com
To ensure that you qualify for the discounted rate please mention GSAS Harvard Biotechnology Club in your correspondence.
We hope you will join us for what promises to be an exceptional forum for networking, deal-making and discussion.
Kind regards
Sachs Associates
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Life Science and Medical Technology Networking Event
|
| Date: |
Thursday December 6, 2007 |
| Description: |
Harvard students and affiliates are cordially invited to a Life Science and Medical Technology Networking Event in Collaboration with Harvard-MIT Division of Health Sciences and Technology
- Interested in meeting your peers and talking about opportunities in the life sciences and medical technology markets?
- Do you want to start the next great biotech company?
- What is like working for a med tech start-up?
- How does one raise venture capital for a med tech start-up?
Come hear about the experiences and lessons learned from leading entrepreneurs who have successfully started companies spun-out of the HMS, Harvard and MIT communities.
Hosted by:
IDG Ventures, Boston
Speakers:
- Christoph Westphal, co-founder and CEO, Sirtris Pharmaceuticals
- Eugene Chiu, Co-Founder and VP of Business Development, Predictive Biosciences and BEP Alum
- Eric Paley, Co-Founder and CEO, Brontes Technologies (recently acquired by 3M)
- John Santini, President and CEO, MicroCHIPS
- Michael Greeley, General Partner, IDG Ventures Boston
Date & Time:
Thursday, December 6, 2007
5:00-7:00 pm, Drinks and Appetizers
(Remarks begin at 5:30 pm)
Location:
McGovern Institute for Brain Research Building 46-3160
Massachusetts Institute of Technology
77 Massachusetts Ave.
Cambridge, MA 02139
For directions and parking go to: http://web.mit.edu/MCGOVERN/html/Contact_us/contact.shtml
RSVP:
Please RSVP mentioning your name, email, designation and school/hospital affiliation by November 28th by responding to pushwaz@thebiotechclub.org
**space is limited. RSVP required. RSVPs on a first come, first serve basis**
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
New England Venture Summit
|
| Date: |
Tuesday November 27, 2007 |
| Description: |
The New England Venture Summit, presented by youngStartup Ventures, is the premier industry gathering connecting senior executives of early stage and emerging growth companies, venture capitalists, angel investors, technology transfer professionals, university researchers, incubators, successful entrepreneurs and premier service providers.
Whether you are an investor seeking access to new early stage deals, or a CEO or Founder of a new venture looking for funding, visibility and growth, the New England Venture Summit is one event you won’t want to miss.
This exclusive full-day Venture Capital Summit will feature:
25+ Venture Capital Speakers
3 Venture Capital Panels
40 of the Hottest Emerging Companies Seeking Funding
Emerging Company Presentations
High Level Networking Opportunities
A Partial List of Venture Capital Firms Confirmed to Speak:
ABS Ventures
Brook Venture Fund
Castile Ventures
Catalyst Health Ventures
EDF Ventures
Foundation Medical Partners
GrandBanks Capital
Greenhill SAVP, LLC
IDG Ventures Boston
Intel Capital
Norwich Ventures
PureTech Ventures
Rho Ventures
Spark Capital
SV Life Sciences
Thomas Weisel Venture Partners
Tullis-Dickerson & Co., Inc.
Audience Profile: Venture Capitalists, angel investors, corporate VCs, CEOs, CFOs and other senior management of early stage and emerging growth ventures, technology transfer professionals and premium services firms.
http://www.youngstartup.com/newengland07/overview.php
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
13th Nobel-Pauling Thanksgiving Dim Sum Biotech Symposium
|
| Date: |
Thursday November 22, 2007 |
| Description: |
13th Nobel-Pauling Thanksgiving Dim Sum Biotech Symposium
Hosted by: Nobel-Pauling (www.pauling.us)
Sponsors: Merck Research Lab, Boston, HKSTP, IDT, SSTK & Cyagen
Date and time (Nov 22, 2007, 9 am to 3 pm
Themes:
1) If Innovation is a seed, where is the soil?
2) Biotech careers: academia vs. start up vs. biotech vs. big pharma & Biotech careers: USA vs. Europe vs. Asia
3) Sea of Learning: Overview of science parks in HK, Shenzhen, Guangzhou, Shanghai & Beijing, India, Germany & Switzerland
1st Speaker: Dr Grace Wong, CSO, ActoKine Therapeutics, Summary reports of two international conferences
A. The discovery of interferons (50 yrs) Sept, 2007, Oxford, England
B. The Power of One Idea: Clonal Selection Theory (50 yrs, Sir Frank Macfarlane Burnet. The Nobel Prize in 1960, (Pauling is for chemistry, Burnet is for immunology & Darwin is for biology) hosted by WEHI, Oct, 2007, Australia.
Other speakers:
Dr. Zhijian Lu, Wyeth
Dr. Xianlu Qu, Merck Research lab, Boston
Dr Huo Li, BiogenIdec
Dr. Kai Wu, Novartis
Mr. Keven Stevens, IDT
Dr. Stephen Lam, HKSTP, Hong Kong
Mr. Kevin Zhou, SSTK, Shenzhen, China
Mr. Lance Han, Cyagen, Guangzhou, China
Dr. Edmund Tsuei, Roche, Singapore
> 10 speakers from biotech & big pharma
Location(China Pearl, 9 Tyler St, Boston)
Pre-Registration is required at www.pauling.us, fee $ 0. Buffet dim sum
contact: Alex Pauling, alexk at pauling.us
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
WPI Venture Forum - “COOPERATION KEY TO BIOPHARMA GROWTH”
|
| Date: |
Tuesday October 9, 2007 |
| Description: |
What are the characteristics of a successful biotech startup? How can startups and established companies in the biopharmaceutical industry find ways to cooperate? On October 9, 2007, Dr. Rainer Fuchs, Vice President of Biogen Idec and Executive Director of the Biogen Idec Innovation Incubator, Bi3, will examine some of biotech¹s productivity issues and address established and novel models for cooperation between startups and established companies. According to Fuchs, compared with other high-tech industries, the biopharmaceutical industry has yet to establish a culture of "co-opetition” while retaining its reputation as a more prolific source of innovation. He will also discuss whether premoney and seed stage companies are critical to the growth and success of biotech and pharma.
The evening case presentation will be by Joe Straight, President and CEO of Synscia, Inc., a Boston-based biopharmaceutical company commercializing a novel product portfolio in ophthalmology. The company is targeting the chronic diseases of age-related macular degeneration (AMD) and proliferative diabetic retinopathy (PDR), both of which have growing patient populations and represent a market opportunity of $10 billion.
The WPI Venture Forum meeting will be held on Tuesday, October 9, 2007, at the Campus Center - Odeum Room, on the WPI campus in Worcester, MA.
Registration and networking begin at 5:30 p.m. and the meeting begins at 6:30 p.m. Registration cost is $15 for members; and $25 nonmembers. Pre-registration is available online at http://www.wpiventureforum.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Panel Discussion: Should I join a startup?
|
| Date: |
Thursday October 4, 2007 |
| Description: |
"Will I get equity in startups?"
"What if the startup closes down or gets acquired?"
"Which are the hottest startups in Greater Boston area?"
"Do I negotiate for more pay from a startup?"
GSAS Harvard Biotech Club has invited the leading entrepreneurs, VCs and scientists in Boston to share insider information about careers in startups and give tips about how to find that rewarding startup job. The confirmed panelists include
- Humera Fasihuddin, Program Director, Invention to Venture, National Collegiate Inventors & Innovators Alliance
- Eric Furfine, Senior VP of R&D, Adnexus Therapeutics
- Ganesh Venkataraman, CSO, Senior Vice President and Co-Founder, Momenta Pharmaceuticals
- Pooja Pathak, Oxford Bioscience Partners
- Padma Narayan, Principal Scientist, TransForm Pharmaceuticals (J & J)
If you'd like to know more about pros and cons about joining a startup, compensation structures, how to identify a good startup etc. you should attend this event. You'll get a chance to ask questions from people who have developed their careers in startups and have mentored many people who started their career in such roles.
Date: October 4th, 2007
Venue: Cannon Room, Building C, Harvard Medical School, 260 Longwood Ave, Boston
Time: 5 to 7 pm
Please feel free to pass this information to your friends, colleagues. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Venture Capital Trends and Outlook in Lifesciences: Lessons for Entrepreneurs
|
| Date: |
Thursday September 20, 2007 |
| Description: |
The GSAS Harvard Biotech Club is organizing a panel discussion targeted at researchers and scientists interested in technology commercialization who plan to start their companies.
This is a first of its kind event where two early stage companies will be making a real pitch to four top VCs in front of the audience. You will get a chance to witness what exactly goes on in boardrooms when entrepreneurs raise capital and get an insiders look on how VCs analyze potential investments. The panel will also be discussing recent investments by their firms, discuss what's hot in the Boston Lifescience space and give their perspective of the funding environment.
To attend, please register at
http://www.tie-boston.org/TGS/EM/viewevent/viewEventPT?id_event=1159&from_where=chapter_homepage
If you are a GSAS Harvard Biotech Club member and a Harvard student, please RSVP to pushwaz@thebiotechclub.org for free admission to the event. The RSVPs will be granted on a first-come-first-served basis.
When: Thursday, September 20, 2007, 6:00 PM – 8:30 PM
Where: Cannon Room, Harvard Medical School, 240 Longwood Ave, Boston.
(The Cannon Room is in the link between buildings C-1 and C-2, on the ground floor)
Map: http://www.hms.harvard.edu/about/maps/quadmap.html
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
McKinsey & Company Presentation
|
| Date: |
Tuesday September 18, 2007 |
| Description: |
For Ph.D. students, Post-docs, M.D. students, Interns, Residents, Fellows and Masters students (non-M.B.A.)
Date: Tuesday, September 18
Time: 6:30 pm - 8:30 pm
Location: The Charles Hotel
One Bennett Street
Cambridge, MA 02138
Presentation Agenda:
6:30 - 7:00 pm Introduction to McKinsey and our work, overview of recruiting steps
7:00 - 7:15 pm Group Q&A
7:15 - 8:30 pm Reception, McKinsey consultants available for small group and individual discussions (refreshments served)
APPLICATION DEADLINE
Application deadline for permanent positions in offices worldwide: Sunday, September 30, 2007.
Please visit our website for more information and to apply: www.apd.mckinsey.com
If you will be finished with your studies in 2008 you should apply for a permanent position by the deadline above. Medical interns, residents and fellows finishing in 2009 may also apply now, for a permanent position, to receive an early decision. Those finishing studies in 2009 may apply for an internship by December 9, 2007. If you will not be applying now, you may register at the same website; registrants will receive e-mails about upcoming events and opportunities.
A CAREER WITH McKINSEY & COMPANY
McKinsey & Company is a management consulting firm that advises senior management of the world's leading organizations on issues of strategy, organization, technology and operations. We are always on the lookout for high caliber individuals to help us fulfill our mission: 1) to help our clients make positive, lasting and substantial improvements to their performance, and 2) to build a great firm that is able to attract, develop, excite and retain exceptional people.
People join us from a wide range of disciplines, and you'll find that we're more interested in the quality of your achievements than your particular area of studies. What is most important to us is evidence of success in your chosen field. Working with us, you will gain exposure to a diverse range of industry sectors and business issues that will not only enhance your career options, but also accelerate the pace of your personal development. In addition, you'll be a member of a core team working directly with senior client executives to address the defining business issues of our time.
So, if you like the idea of a career alternative that will stimulate and challenge the very brightest minds together with the opportunity to work with highly motivated colleagues in a supportive, team-based environment, please join us for our presentation.
Also, please visit our website at www.apd.mckinsey.com to learn more about McKinsey & Company. The website features profiles of consultants with backgrounds similar to your own, information about selection criteria, application tips, and the on-line application form.
Please feel free to forward this e-mail to graduate students who might be interested in learning about career opportunities with McKinsey & Company.
Please contact the APD Northeast recruiter should you have questions:
Emily, Recruiter
McKinsey & Company
emily_marquis@mckinsey.com
www.apd.mckinsey.com
OTHER PRESENTATIONS AT HARVARD
Kennedy School of Government
Tuesday, September 25, 6:00 - 8:00 pm
Starr Auditorium, 79 JFK Street
Harvard Business School (First-Years)
Tuesday, November 13, 7:00 - 9:00 pm
The Charles Hotel
Harvard Undergraduate Presentation
Monday, September 24, 6:30 - 9:00 |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Biotech Industry Study Group
|
| Date: |
Wednesday July 18, 2007 |
| Description: |
The Biotech Industry Study Group will hold its first meeting on Wednesday, July 18th at 6PM in the Cannon Room, Building C, HMS campus. Our invited speaker will be Dr. Sandrock, Senior Vice President of Neurology Research and Development at Biogen Idec. We invite you to attend.
The Biotech Industry Study Group (BISG) is a group designed to help graduate students and post-docs considering a career in biotech or pharma learn more about the companies and their research. The meetings will be designed to provide an overview of the company and then, by way of an invited speaker, introduce members to a prominent researcher in the company. Hopefully this will result in the members developing a sense of which company's research and culture provide the best fit and then, when the job search commences, they will already have a contact inside the company.
Alfred W Sandrock, Jr., MD, PhD is Senior Vice President, Medical Research-Neurology at Biogen Idec, Inc. in Cambridge. A board certified neurologist, he leads the team that oversees clinical development in neurologic indications. He is also assistant clinical professor of neurology at Harvard Medical School, and clinical associate in neurology at MGH.
Dr. Sandrock received his MD from HMS and his PhD in neurobiology from Harvard University in Cambridge. He completed an internship in medicine, a residency and chief residency in neurology, and a clinicalfellowship in neuromuscular disease in clinical neurophysiology (electromyography) at MGH.
His contributions to the literature include articles on the identification of molecules that promote axonal regeneration, the role of neuregulin at the neuromuscular junction, as well as multiple articles on therapeutics in multiple sclerosis.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
"How to write a business plan" - an interactive seminar
|
| Date: |
Tuesday May 1, 2007 |
| Description: |
Do you have an idea for a new life science venture? Are you trying to raise money and generate investor interest?
Ian Carver, Executive Director of the Entrepreneurial Services Center, PricewaterhouseCoopers LLP will lead an interactive discussion on successful strategies for crafting a winning business plan for life science start-ups.
Date: Tuesday, May 1st, 2007
Time: 5:30pm-7pm
Location: Cannon Room, C Building, Harvard Medical School Quadrangle
Ian is a director at the Entrepreneurial Services Center within PricewaterhouseCoopers’ Technology, InfoComm and Entertainment (TICE) Practice. His focus is on providing start-up and early-stage technology and life sciences companies with access to informal business advisory services to assist their financing and corporate development initiatives. Services typically include:
• business plan review and critique
• introductions to an extensive network of venture capital and angel investor contacts
• introductions to appropriate banking, investment banking and legal resources
• advice regarding the accounting and tax ramifications of business decisions
• assistance, where feasible, in finding strategic partners within PricewaterhouseCoopers’ lines of business and client network
• access to benchmarking and best practices industry and human resource data to improve company performance and growth
• introductions to potential temporary controller and CFO candidates as well as access to PricewaterhouseCoopers’ Career Services Group to fill a full-time CFO position
• access to audit and tax compliance services specifically designed to meet the needs of early stage, venture backed technology and life sciences companies
Ian has an MBA from the Fuqua School of Business at Duke University and brings over 20 years of operational, general management and business development experience to his position at PricewaterhouseCoopers' Entrepreneurial Services Center.
Refreshments will be served.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
"Getting the right message to the right ears" Seminar Event
|
| Date: |
Wednesday April 25, 2007 |
| Description: |
If you choose a single person in the whole world to be on the other end of the line when the phone rings, and say, "tell me about your product or service," who would that person be? Why? When launching a new product or service, you will need to get the right people to hear your message and react. At the same time, you will have extremely limited time and limited budgets. The speaker will lead a discussion focused on how to get the message to the right people at the right time for the right results. This is will be an interactive presentation and will make use of many real-world examples, including how a small nanotechnology company with a potentially explosive product built a story that outpaced the competition, educated its audiences, and led to a full pipeline.
Speaker Bio:
Nicolas A. Boillot, President, Hart-Boillot, LLC
As co-founder of Hart-Boillot, Mr. Boillot has guided the agency to profitability in every year since it was founded in 1999. In his role as Account Director, he has managed significant communications campaigns for brands such as HP, Gore Bike Wear, EMC, Fairchild Semiconductor, Vicor and NanoHorizons. He has also worked in higher education as a teacher and in finance, where he analyzed European businesses for a group of American investors who sought acquisitions.
Registration is NOT required for this event! To help us out with expected numbers though, please let us know by signing up via this survey (it'll take 5 seconds!).
http://www.surveymonkey.com/s.asp?u=843043685865 |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
French American Innovation Day
|
| Date: |
Monday October 16, 2006 |
| Description: |
Website: http://www.france-science.org/faid/
The Office of Science and Technology of the Embassy of France and Institut
Curie are delighted to invite you to the 5th French-American Innovation Day
(FAID), an event organized yearly in Boston.
The event's goal is twofold:
- to promote research and innovation in areas where our two countries share
a competitive advantage.
- to foster French-American cooperation between laboratories and companies.
This year, it will take place on Monday and Tuesday October 16th and 17th
2006 at the Harvard Medical School in Boston with the participation of H.E.
Jean-David LEVITTE, the Ambassador of France to the US and Mina Bissell,
Ph.D., Distinguished Scientist, UC Berkeley.
The aim of the event is to show the more recent contributions and the
perspectives
of imaging in research and clinical practice with a focus on Cancer
Several aspects will be presented such as the phenotypic screening with the
aim of
developing tailored treatments for cancer patients, the imagining in vivo
immune response,
the development of pathogens-based technology for immuno-therapy
treatment of cancer, elasticity imaging for breast cancer diagnosis and the
most recent
achievements in the field of proton and carbon therapy.
Networking opportunities will be offered during the two-day event for
attendees
to meet new partners in laboratories and companies.
Registration is free but mandatory (limited seating). For further
information, please check our website at www.france-science.org/faid/
Contacts
- Jean-Jacques PIERRAT, Office for Science and Technology,
science@consulfrance-boston.org
- Emmanuelle Deponge, Institut Curie
emmanuelle.deponge@curie.fr
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
In vivo information… …from in vitro tools
|
| Date: |
Monday October 16, 2006 |
| Description: |
WatchFrog creates and markets innovative solutions for the in vivo selection of a wide range of chemical, pharmaceutical and cosmetic substances.
On the one hand, culture-based in vitro screening risks eliminating interesting leads while in vivo screening is considered too slow and too expensive. WatchFrog incorporates in vivo significance with early in vitro stages, accelerating drug discovery.
The new generation of WatchFrog tests “light up”, providing biological answers using fluorescent-based screening in translucent amphibian models.
Amphibian development reproduces every key event of vertebrate organogenesis within an exceedingly short time frame (72h).
This is why, for years, scientists have used the tadpole for studying the cellular basis of cancer: apoptosis, immune response, proliferation.
Similarly the model can be used to assess neurotoxic effects of potential therapeutic agents.
Now, molecular signals associated with cell division and death can be followed on-line.
Our new generation small model organisms allows these processes to be studied in a tissue specific manner using semi-robotized screening.
For more information and online registration: www.bioteam.fr
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Equity Allocation and Your Venture: Noam Wasserman "Rich vs King"
|
| Date: |
Wednesday October 11, 2006 |
| Description: |
Many conversations among Harvard Alumni Startups members have focused on one decision that all founders face: how to slice the ownership pie. Now is your chance to gain new insights on the topic from your peers and from a special guest speaker.
On October 11th, Harvard Alumni Startups will host an evening with Noam Wasserman, (PhD 2002, MBA 1999). Noam, now an Assistant Professor at HBS, will talk about his paper, "Rich vs. King" -- and will share the highlights from his research on the relationship between startup success and equity allocation.
When: October 11th, 7-9pm
Where: 1730 Cambridge Street (CGIS South Building Room S020 on Harvard campus), Cambridge, MA
$20 payable at the door. Free with valid Harvard student ID.
This event is made possible by the generous sponsorship of Glance Networks (www.glance.net).
Please register for this event via the following form available at:
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
GSAS Harvard Biotechnology Club 7th Annual Business Plan Competition
|
| Date: |
Monday May 15, 2006 |
| Description: |
The GSAS Harvard Biotechnology Club announces the seventh annual Biotechnology Business Plan Competition with sponsorship from Merck Research Laboratories (MRL)-Boston, Cummings Properties.
The GSAS Harvard Biotechnology Business Plan Competition is unique in that it focuses exclusively on biotechnology start-ups. The 2005 Biotechnology Business Plan competition is open to entrepreneurs, students and professionals worldwide, and does not require Harvard University affiliation. The competition offers a $5,000 cash award for the first prize. An additional prize of a one-year lease for 1000 sq ft of lab/office space ($25,000 value) has been generously donated by Cummings Properties and will be granted to the highest placing entry that can utilize the space. The competition presents the opportunity for early stage biotechnology companies to have their business plans reviewed by seasoned venture capitalists and other biotechnology experts in the Boston area.
Schedule Of Events
Leading up to the competition, the GSAS Harvard Biotechnology Club is hosting a series of panel discussions. These panels are designed to address just a few of the many issues faced by entrepreneurs trying to start a company. All seminars and panels are open to the public.
Wednesday, March 22nd, 4:00 - 6:00pm
Getting Your Biotech Start-Up Seed Funded
Speaker: Steve Wardell: Principle, Apeiron Partners LLC
Harvard Medical School, New Research Building, HIM Lecture Room 1
Thursday, April 25th, 4:00 - 6:00pm
Alternative Funding and Business Law Panels
Harvard Medical School New Research Building, Rotunda
Monday, May 1st, 4:00 - 6:00pm
Venture Capital and Intellectual Property Panels
Harvard Medical School, New Research Building, Rotunda
Monday, May 15th, 5:00pm
Business Plan Competition Submission Deadline
Friday, June 2nd, 5:00pm
Finalist Presentations and Awards Ceremony
For more information about the Biotechnology Business Plan Competition, the Biotech Club, or becoming a sponsor, visit www.thebiotechclub.org/industry/startup/bplan.php or contact Patrick Loerch, patrick@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Consulting Career Panel
|
| Date: |
Wednesday May 10, 2006 |
| Description: |
The GSAS Harvard Biotechnology Club
Presents:
What: Consulting Career Panel
When: Wednesday, May 10th 2006, 4-6pm
Where: Harvard Medical School
260 Longwood Avenue
C-Building Cannon Room
Meet successful scientists & learn about their unique career paths. Explore the possibilities of consulting in the biotech/pharma industry as a career option for scientists. Please join us for an interactive & informative discussion. Light refreshments will be served.
Panelists:
• Chris Pashos, Ph.D.
Executive Director: Health Economics Research, Abt Associates
• Avi Kogan, Ph.D.
Consultant, The Monitor Group
• Antonio Pregueiro, Ph.D.
Senior Business Analyst, Trinity Partners
• Kimberly Howland, Ph.D.
Manager, Health Advances, LLC
• Geoff Whitehead, Ph.D.
Associate, PRTM
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Venture Capital and Intellectual Property Panels
|
| Date: |
Monday May 1, 2006 |
| Description: |
Leading up to the 7th Annual Business Plan Competition, the GSAS Harvard Biotechnology Club presents the Venture Capital and Intellectual Property Panels
What: Venture Capital and Intellectual Property Panels
When: Monday, May 1st, 4:00 - 6:00pm
Where: Harvard Medical School, New Research Building, Rotunda
Boston, MA
The venture capital panel discussion will feature VCs from the Boston area with a focus on the life science industry. Topics covered will include the current state of investment in the biosciences, recommendations on writing and marketing a strong business plan and criteria used by VCs to assess a new business idea. Panelists will field questions from the audience, with a focus on issues pertinent to scientists aspiring to launch business ventures in the life sciences
The IP panel will feature experienced attorneys and technology transfer specialists discussing how to navigate the licensing and patent hurdles involved in bringing a technology to the marketplace. The format will be highly interactive, with audience participation encouraged.
Intellectual Property Panelists:
Thomas Saunders, J.D.
Patent Law Attorney, Brown Rudnick Berlack Israels
O. Prem Das, Ph.D.
Office of Technology Licensing & Industry Sponsored Research, HMS
Andrea Schievella, Ph.D.
Technology Transfer Officer/Business Development & Licensing, MIT
Jeffrey L. Quillen, J.D.
Patent Law Attorney, Foley Hoag LLC
Venture Capital Panelists:
Jeffrey Moore
Associate, Research Corporation Technologies
Amir Nashat
Principle, Polaris Ventures
Zach Jonasson
Senior Principle, Seaflower Ventures
For more information on the Business Plan Competition or the venture capital and intellectual property panels contact Kanchan Mirchandani or visit http://www.thebiotechclub.org/industry/startup/bplan.php |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Alternative Funding and Business Law Panels
|
| Date: |
Tuesday April 25, 2006 |
| Description: |
Leading up to the 7th Annual Business Plan Competition, the GSAS Harvard Biotechnology Club presents the Alternative Funding and Business Law Panels.
What: Alternative Funding and Business Law Panels
When: Thursday, April 25th, 4:00 - 6:00pm
Where: Harvard Medical School New Research Building, Rotunda
Boston, MA
Alternative Funding Panel: The alternative funding panel focuses on less publicized sources of funding options for entrepreneurs. With venture capitalists preferring to invest in later stage start-up and requiring a larger percentage of ownership entreprenuers are looking elsewhere for the funds they require to get their companies off the ground. Panelists will discuss funding options available to entrepreneurs apart from venture capitalists, including SIBR grants, loans and angel investing. The format will be informal and we encourage audience members to bring questions.
Business Law Panel: New companies often start up on nothing more than the merit of a good idea. Entrepreneurs don't give much thought to how to deal with professional vendors such as bankers, attorneys, accountants and so on. With a little thought and effort, entrepreneurs can ensure to get the most from your vendor/customer/employee by building good relationship with your attorney. Your attorney's primary goal is to protect your interests. Attorneys take that job seriously, and their training gives them a different perspective than that of many entrepreneurs. In this event, entrepreneurs, scientists, and attorneys will share their perspectives on topics including: Corporation and liability, Corporate Structure, Incorporation, Disclaimers and Founders stock.
Alternative Funcing Panelists:
Janice Bourque
Senior Vice President and Group Head-Life Sciences, Comerica Bank
Dana Ono, Ph.D.
Managing Director, Life Sciences, VIMAC Ventures LLC
Phil Weilerstein
Executive Director, National Collegiate Inventors & Investors Alliance (NCIIA)
John J. Schwartz, Ph.D.
Director - Life Sciences, Stage1 Strategies
Business Law Panelists:
Gabor Garai, J.D.
Partner, Foley & Lardner LLP
Lin J. Hymel, Ph.D., JD
Associate, Edwards Angell Palmer & Dodge LLP
Roque El-Hayek, MD, JD
Associate, Wolf, Greenfield & Sachs PC
For additional information about the Biotechnology Business Plan Competition, the Biotech Club visit www.thebiotechclub.org/industry/startup/bplan.php or contact Patrick Loerch, patrick@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Women in Biotechnology, Pharmaceutical and Biotech Research Panel
|
| Date: |
Monday April 17, 2006 |
| Description: |
Panelists:
Grace Wong, Ph.D.
Chief Scientific Officer, ActoKine Therapeutics
Vivian Berlin, Ph.D.
Principal at BIOLyNX LLC
The Women in Biotechnology series will be an excellent opportunity to meet with successful women who have taken different approaches to science and have all excelled. This panel will examine the possibilities of research in the pharmaceutical and biotechnology industry as a career for scientists. The three major themes for the panel discussion will be: How these successful women go to where they are now, how they overcame any extra challenges they faced in their career, and how did they deal with the issues surrounding the creation of a healthy balance between professional success and family development. Please join us for an interactive and educational discussion.
The event will take place in the Cannon Room, C building, Harvard Medical School Quad, 240 Longwood Ave, Boston, MA 02115
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Women in Biotechnology: Intellectual Property, Venture Capital, and Patent Law
|
| Date: |
Monday April 3, 2006 |
| Description: |
In this seminar series, we will feature several courageous women who were trained in biological sciences, and made many career transitions in finding and pursuing their passions, and in balancing and living their lives. They come from different backgrounds, travelled different paths, and balanced their life in different ways. But they have one thing in common. They all have dared to venture out of their comfort zone and begin living fulfilling lives.
The Panelists:
Debra A. Peattie, Ph.D.
Chief Technology Officer, Valeo Mecial Inc.
Leena H. Karttunen, Ph.D., J.D.
Patent Attorney, Nixon Peabody LLP
Beth E. Arnold, M.S., J.D.
Partner, Foley Hoag LLP
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Funding Innovation: Steve Wardell: Principle, Apeiron Partners
|
| Date: |
Wednesday March 22, 2006 |
| Description: |
Funding Innovation:
Who: Steven Wardell: Principle, Apeiron Partners
Where: Harvard Medical School, HIM Room 138
When: Wednesday March 22nd, 4-6pm
The life science industry has changed dramatically over the past 5 years, and the biotech venture capital industry even more so, leading to the creation of the “Capital Gap” in the funding of life science start-ups. What sort of start-ups are venture funds willing to fund today and what stage do they have to be at in order to attract funding? Which venture funds are still willing to invest in early-stage start-ups? Steve Wardell, a Principal at Apeiron Partners LLC, a boutique life science investment bank with a $100m venture fund, will address these questions and explain what his fund is currently investing in.
BIO:
Steven Wardell is a Principal at Apeiron Partners. He has worked on over 25 major life science engagements with Apeiron Partners and has over 7 years of business development, corporate finance, and financial analysis experience. Prior to Apeiron Partners, he worked in M&A at Salomon Smith Barney on Wall Street. Mr. Wardell assists Apeiron Partners clients in business development and corporate finance transactions and frequently fills an operating role at a newco as part of an engagement. Before Apeiron Partners, Mr. Wardell worked on Wall Street where he participated in over $20 billion worth of M&A and financing transactions at Citigroup (Salomon Smith Barney) in healthcare, technology, and other sectors. Steve is the Director for Dinner Series of the Harvard Business School Health Industry Alumni Association." He holds an MBA from Harvard Business School, an MPhil from Cambridge University, and a BA from Harvard College. NASD registered broker-dealer, Series 7, 24 & 63.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Intrapreneurial & Entrepreneurial Women in Life Sciences --blazing their own trails
|
| Date: |
Monday March 20, 2006 |
| Description: |
What: Intrapreneurial & Entrepreneurial Women in Life Sciences --blazing their own trails
When: Monday March 20th, 4:30pm-6:00pm
Where: Cannon Room, C Building
Harvard Medical School Quad
240 Longwood Ave, Boston
In this seminar series, we will feature several courageous women who were trained in biological sciences, and made many career transitions in finding and pursuing their passions, and in balancing and living their lives. They come from different culture background, went through different paths, and balanced their life in different ways. But they have one thing in common. They all have dared to venture out of their comfort zone and begin living fulfilling lives.
Jiahong Juda, PhD, Co-Founder of WEST: Moderator
Dr. Jiahong Juda is the co-founder, and recent President and CEO of Women Entrepreneurs in Science and Technology (WEST). Trained as a physicist, she has always had a passion for applied science. About five years ago, she made the transition from the academic environment to a startup company, where she discovered her entrepreneurial aspiration. After searching extensively, she did not find a suitable environment for "business clueless" scientists or engineers to learn and develop intra/entrepreneurial skills until she and two colleagues co-founded WEST in 2000. Jiahong has recently retired as president of WEST, is currently working as a consultant and developing a course entitled ‘Personal Strategic Growth’ which was recently showcased at MIT.
Vivian Berlin, PhD, Principle BIOLyNX LLC
Vivian Berlin has 15 years of experience in the biotechnology industry holding positions in research management and business development at Vertex Pharmaceuticals, Mitotix and GPC Biotech. She led multiple research efforts moving programs from concept to late preclinical development. Dr. Berlin established proprietary positions in a number of therapeutic areas and has 13 issued patents. She is currently a Principal at BIOLyNX LLC providing research and corporate development strategy services to companies in the life sciences. She is also engaged in founding a company focused on the development of a diagnostic for ovarian cancer. Dr. Berlin received her M.S. at the Harvard School of Public Health, Ph.D. in Biology at Stanford University and postdoctoral training at the Whitehead Institute at MIT.
Lydia Villa-Komaroff, PhD, CSO Cytonome, Inc
Lydia Villa-Komaroff began her research career under the tutelage of David Baltimore and Harvey Lodish at MIT, and received a Ph.D. in Cell Biology in 1975. Her varied and active professional life includes research positions at Harvard University, the University of Massachusetts Medical Center, Cold Spring Harbor, and Children's Hospital in Boston. From 1998 to 2003 she was Vice President for Research at Northwestern University in Illinois and from 2003 to 2005 she served as Vice President for Research and Chief Operating Officer of the Whitehead Institute in Cambridge. She is currently Chief Scientific Officer of Cytonome.
She is a member of the Hispanic Engineer National Achievement Hall of Fame and a fellow of the Association for Women in Science. She has served on review committees for the National Institutes of Health and National Science Foundation. She was a member of the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects, the National Research Council Committee on the Structure of NIH, the congressionally mandated National Science Foundation Committee on Equal Opportunity in Science and Engineering, as well as the National Science Foundation Advisory Committee for the Biology Directorate, which she chaired from 1997 to 1998. She was a member of the National Advisory Neurological Disorders and Stroke Council from 2000 to 2004 and was elected to the Board of Directors of the American Association for the Advancement of Science in 2001. She is a founding member of the Society for the Advancement of Chicanos and Native Americans in Science and has been both a board member and vice president of the organization. She was appointed to the Board of Directors of Transkaryotic Therapies, Inc (TKT) in 2003, a biopharmaceutical company that developed products for the treatment of rare diseases. She became Chair of the Board in January 2005 and guided the deliberations and process that led to the sale of TKT for $1.6B.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
7th Annual GSAS Harvard Biotechnology Club Business Plan Competition
|
| Date: |
Monday March 13, 2006 |
| Description: |
The GSAS Harvard Biotechnology Club Announces:
The 7th Annual Biotechnology Business Plan Competition
The GSAS Harvard Biotechnology Club announces the seventh annual Biotechnology Business Plan Competition with sponsorship from Merck Research Laboratories (MRL)-Boston, Cummings Properties.
The GSAS Harvard Biotechnology Business Plan Competition is unique in that it focuses exclusively on biotechnology start-ups. The 2005 Biotechnology Business Plan competition is open to entrepreneurs, students and professionals worldwide, and does not require Harvard University affiliation. The competition offers a $5,000 cash award for the first prize, and a $1,000 cash award for second prize. An additional prize of a one-year lease for 1000 sq ft of lab/office space ($25,000 value) has been generously donated by Cummings Properties and will be granted to the highest placing entry that can utilize the space. The competition presents the opportunity for early stage biotechnology companies to have their business plans reviewed by seasoned venture capitalists and other biotechnology experts in the Boston area.
Schedule Of Events
Leading up to the competition, the GSAS Harvard Biotechnology Club is hosting a series of panel discussions. These panels are designed to address just a few of the many issues faced by entrepreneurs trying to start a company. All seminars and panels are open to the public.
Wednesday, March 22nd, 4:00 - 6:00pm
Getting Your Biotech Start-Up Seed Funded
Speaker: Steve Wardell: Principle, Apeiron Partners LLC
Harvard Medical School, New Research Building, HIM Lecture Room 1
Thursday, April 25th, 4:00 - 6:00pm
Alternative Funding and Business Law Panels
Harvard Medical School New Research Building, Rotunda
Monday, May 1st, 4:00 - 6:00pm
Venture Capital and Intellectual Property Panels
Harvard Medical School, New Research Building, Rotunda
Monday, May 15th, 5:00pm
Business Plan Competition Submission Deadline
Finalist Presentations and Awards Ceremony
Date & Location: To Be Announced
For more information about the Biotechnology Business Plan Competition, the Biotech Club, or becoming a sponsor, visit www.thebiotechclub.org/industry/startup/bplan.php or contact Patrick Loerch, patrick@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Networking 101
|
| Date: |
Friday January 27, 2006 |
| Description: |
What: Networking 101
Who: Michele Ayan: President & Founder of 180 Global Marketing
When: January 27, 2006: 4-6pm
Where: Harvard Medical School Quadrangle, Cannon Room
Networking, it’s one of those topics you hear about no matter what field you’re in, even medicine and science. Most people acknowledge that networking plays a key role in building a successful career in both industry and academia.
However, just what networking is and how it can be accomplished remains a mystery for many people, especially in an industry setting. As a result, most of us do not give networking much thought until suddenly we find ourselves searching for our next (or first) career move, sitting at home with our rolodex (if we have one) and wondering “Who do I call now?”
Michele Ayan, of 180 Global Marketing, will give an interactive seminar on the “Do’s and Don’ts” of networking. Topics will include: how to get started, building and maintaining your network, as well as some advanced networking techniques.
Michele Ayan is the President and Founder of 180 Global Marketing, a marketing firm dedicated to driving the success of its clients. Ms. Ayan has over 10 years of Professional Marketing experience. Before launching her consulting practice, Michele served as the Director of Marketing of Testa, Hurwitz & Thibeault, LLP, a leading global law firm that serves emerging growth companies and the venture capital and private equity communities that finance them.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
GSAS Harvard Biotechnology Club Career Fair
|
| Date: |
Thursday October 6, 2005 |
| Description: |
GSAS Harvard Biotechnology Club Career Fair
Thursday, October 6th, 2005, 1-5 PM
Harvard Medical School
Boston, MA
Have (or soon will have) a PhD and are looking for a non-academic career? Need talented PhDs with biological/medical research experience for your company? Please join us on October 6, 2005 from 1-5 PM for the GSAS Harvard Biotechnology Club Career Fair at Harvard Medical School.
This year’s fair is sponsored by Science Careers and will include representatives from a mix of biotech, pharmaceutical, patent law and consulting companies looking to hire PhDs. A variety of non-academic career options, from bench science to business applications, will be presented through company booths, presentations and panel discussions. In previous years an estimated 1000 Harvard-affiliated job seekers, including graduate students, postdocs, fellows, and medical students have attended and as many as 34 companies have participated in this event.
Career Fair Schedule
Tuesday, October 4th
Panel: Career Opportunities in Industry: Merck-Boston
Merck Scientists discuss and contrast research in industry and academia. They talk about the career opportunities at Merck-Boston, what they look for in scientists and give insight into the decision on whether to make the transition from academia to industry.
Time : 4:00 to 5:30 PM
Venue : C-Building, Cannon Room
Harvard Medical School Quadrangle
Longwood Medical Area (map)
Boston, MA 0211
Wednesday, October 5th
Panel: Alternative Careers in Science
The GSAS Harvard Biotechnology Club presents a panel discussion addressing non-traditional career paths for scientists. Panelists with Ph.Ds in the life-sciences who have excelled in areas encompassing Business Development, Biotechnology Consulting, Venture Capital and Patent Law will shed light on exciting choices currently available to scientists seeking to make meaningful contributions outside the realm of traditional scientific research.
Time : 5:00 to 6:00 PM
Venue : New Research Building
3rd Floor Rotunda
Harvard Medical School
Longwood Medical Area (map)
Boston, MA 02115
Thursday, October 6th
Annual Career Fair
Time : 1:00 to 5:00 PM
Venue : New Research Building
3rd Floor Rotunda
Harvard Medical School
Longwood Medical Area(map)
Boston, MA 02115
1-5PM Company Tables
1-4PM Company Presentations
Companies that are interested in participating should register by September 6, 2005, using the company registration form at http://www.thebiotechclub.org.
More information can be found at our website http://www.thebiotechclub.org. Further questions can be addressed to Patrick Loerch at patrick@thebiotechclub.org.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biotechnology Club Announces the Winners of the 2005 Biotechnology Business Plan Competition
|
| Date: |
Friday June 17, 2005 |
| Description: |
Boston, June 10 2005 -- In the 2005 Biotechnology Business Plan Competition organized by the GSAS Harvard Biotechnology Club, Claros and Vascular Precision were awarded the top prizes by a panel of judges composed of leading venture capital firms.
At the award ceremony was hosted by Brown Rudnick Berlack Israels LLP Claros was awarded the first prize in the competition. The judges clearly favored Claros in the competition stating that they possess the combination of a solid team and a clear solution to complex problem with a large market. Claros has designed an easy-to-use device that performs complex immunoassays with minimal time and resources. The company has chosen the STD market to launch the device where it is primed for rapid adoption in the home market due to privacy issues with STD testing. Thekla Diehl, the director of the competition said that with their management team and novel device it was clearly a winner for this competition. Claros walked away with a legal package from Brown Rudnick, $25,000 credit towards leasing lab space with Cummings Properties and a $5000 cash prize.
The second place prize was awarded to Vascular Precision who have developed a novel vascular closure device for large arteriotomy sites that meets a well-defined market with unmet needs. Vascular Precision's products enable surgeons to close both large and small
arteriotomies percutaneously and achieve complete hemostasis along the
entire arteriotomy profile, regardless of its size. Vascular Precision was also awarded a legal package from Brown Rudnick as well as a $1000 cash prize.
Judges in the competition included representatives from the following venture firms: Flagship Ventures, Oxford Bioscience Partners, CPP Capital, Versant Ventures, Seaflower Ventures, Venrock and PureTech Ventures. The prizes and competition were made possible through the continued support of Brown Rudnick Berlack Israels LLP, Cummings Properties and Merck Research Laboratories-Boston.
The GSAS Harvard Technology Club is a non-profit organization with over 5,000 members in both industry and academia. Among other activities, the club hosts events and provides services that allow members to explore the worlds of business and biotechnology. The Club’s mission is to bridge the gap between industry and academia by building relationships with companies operating in the biotechnology and healthcare sphere. Corporate sponsorship support all club activities and operations.
To learn out more about the 2005 Biotechnology Business Plan Competition or the GSAS Harvard Biotechnology Club please contact Patrick Loerch, Managing Director (617) 938-6228 – patrick@thebiotechclub.org or visit www.thebiotechclub.org.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
The GSAS Harvard Biotechnology Club Announces the 6th Annual Biotechnology Business Plan Competition
|
| Date: |
Sunday May 15, 2005 |
| Description: |
The GSAS Harvard Biotechnology Club
Announces the Sixth Annual Biotechnology Business Plan Competition
Brown Rudnick and Merck Research Laboratories Sponsor Competition
to Foster Emerging Technology Companies
The GSAS Harvard Biotechnology Club announces the sixth annual Biotechnology Business Plan Competition with sponsorship from the international law firm of Brown Rudnick Berlack Israels LLP, Merck Research Laboratories (MRL) and the Technology & Entrepreneurship Center at Harvard (TECH).
The GSAS Harvard Biotechnology Business Plan Competition is unique in that it focuses exclusively on biotechnology start-ups. The 2005 Biotechnology Business Plan competition is open to entrepreneurs, students and professionals worldwide, and does not require Harvard University affiliation. The competition offers a $5,000 cash award for the first prize, and a $1,000 cash award for second prize. It also presents the opportunity for early stage biotechnology companies to have their business plans reviewed by seasoned venture capitalists and other biotechnology experts in the Boston area.
Leading up to the competition, the GSAS Harvard Biotechnology Club is hosting a series of workshops designed to assist applicants. Workshops will teach the basics of writing a business plan and how to tackle some of the corporate, intellectual property and organizational hurdles faced by start-up companies in the biotech sector. This series will conclude with our annual Venture Capital and IP/Tech Transfer Q&A panels. All of the events are open to the public and will be held in the rotunda of the Harvard Medical School NRB building in Boston, MA.
For additional information about the Biotechnology Business Plan Competition, the Biotech Club, or becoming a sponsor, please contact Thekla Diehl, tdiehl@thebiotechclub.org or Patrick Loerch, patrick@thebiotechclub.org or visit www.thebiotechclub.org.
Schedule of Events:
Wednesday, April 13th, 4:00 – 6:00pm
Speakers: Dr. Joe Lassiter and Dr. Mike Roberts, Harvard Business School
4:00 - 4:50pm The Basics of Writing a Business Plan
5:10 - 6:00pm A Critique of 2004’s Competition Finalists, NeuroHealing Pharmaceuticals
and Mujisan Pharmaceuticals
Thursday, April 28th, 4:00 – 6:00pm
Speakers: Dr. Lee Fleming and Dr. Noam Wasserman, Harvard Business School
4:00 - 4:50pm Founders and Teams in a Start-up Company
5:10 – 6:00pm Cambridge vs Silicon Valley as Start-up Environments
Thursday, May 5th, 4:00 – 6:00pm
Venture Capital and IP/Tech Transfer Panels
Panelists: To Be Announced
Sunday, May 15th
Business Plan Competition Submission Deadline
Thursday, June 2nd, 7:00 – 9:00pm
Final Awards Ceremony and Reception
|
| File Attachments: |
File (None)
JPEG(None)
PDF()
|
|
Annual Venture Capital and IP/Technology Transfer Panel Discussions
|
| Date: |
Thursday May 5, 2005 |
| Description: |
THE 6th ANNUAL GSAS HARVARD BIOTECHNOLOGY CLUB BUSINESS PLAN COMPETTION VENTURE CAPITAL AND IP/TECH TRANSFER PANELS
May 5th 2005
Harvard Medical School NRB 3RD Floor Rotunda
Sponsered by Brown Rudnick Berlack Israels LLP
and Merck Research Laboratories-Boston
A moderated discussion of what venture capitalists look for in a start-up company, accompanied by a look at some of their most recent funding decisions. This will be followed by an overview of how to navigate the licensing and patent hurdles involved in bringing a technology into the marketplace and how much IP is enough.
Venture Capitol Panel:
· Doug Cole, Flagship Ventures
· Kolol Pal, Pure Tech Ventures
· Monica Vnuk, Oxford Bioscience Partners
· David Stone, Flagship Ventures
IP/Tech Transfer Panel:
· Brenda Maning, Vice President, Children’s Hospital Tech Transfer Office
· Kenneth Levin, Senior Technology Manager, Harvard Medical School Tech Transfer Office
· Chester Bisbee, Director, University of Massachusetts Medical School Tech Transfer Office
· Thomas Saunders, Partner, Brown Rudnick Berlack Israels LLP
When: Thursday, May 5th, 2005 4:00 PM
Where: Harvard Medical School
New Research Building 3rd Floor Rotunda
77 Avenue Louis Pasteur
Boston, MA 02115
|
| File Attachments: |
File (531_VC_IP_Panel_Flyer.doc)
JPEG(None)
PDF(None)
|
|
A PRACTICAL WORKSHOP ON THE BASICS OF WRITING A BUSINESS PLAN
|
| Date: |
Wednesday April 13, 2005 |
| Description: |
A PRACTICAL WORKSHOP ON THE BASICS OF WRITING A BUSINESS PLAN
To kick-off the Sixth Annual Biotechnology Business Plan Competition the GSAS Harvard Biotechnology Club would like to announce the first of its business plan workshops.
On April 13th at the Harvard Medical School NRB Building Professors Joe Lassiter and Mike Roberts from the Harvard Business School will lead a workshop on the basics of writing a business plan. They will describe the basic anatomy of a business plan, as well as supply a practical guide on how to begin and where to find the information you’ll need to compose a viable plan. Following a brief coffee break, the second half of the workshop will consist of a detailed critique of 2004’s Competition | |
|
